Application of high throughput rapid detection technology for pathogenic pathogens

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200057185

Enrollment

Unknown

Registered

2022-03-02

Start date

2022-02-15

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Gold Standard:The fluorescence quantitative PCR method with registration certificate on the market was selected as the reference method.

Index test:Seasonal H1, H3, pandemic H1N1 (2009), avian influenza H5, H7, H9, influenza A virus detection, Victoria, Yamagata two types of influenza B virus detection.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The remaining clinical samples of respiratory virus nucleic acid 6 test or influenza A and B antigen test were collected from patients with acute respiratory tract infection symptoms such as fever or cough in Shenzhen Second People's Hospital.

Exclusion criteria

Exclusion criteria: 1. Samples with volume less than 500µL are considered invalid samples; 2. Samples unable to complete double-tube parallel determination due to instrument or human factors (failure of the test process and failure of retest or failure of retest).

Design outcomes

Primary

Measure	Time frame
Positive coincidence rate;Negative coincidence rate;The total coincidence rate;	—

Countries

China

Contacts

Public ContactLiu Xiuqing

Shenzhen Second People's Hospital

1522613518@qq.com+86 13530325819

Outcome results